- £81.91bn
- £95.80bn
- £32.67bn
REG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - GSK - segment and product sales reporting changes
AnnouncementREG - GlaxoSmithKline PLC - Publication of 2022 AGM Notice
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - FDA update: Cabenuva oral lead-in now optional
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Issuance of Notes
AnnouncementRCS - Osler Diagnostics Ld - Osler Diagnostics Announces a Company Update
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Appointments to Designate Haleon Board
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
Announcement